Supportive Care

Twitter feed

RT @NatureNews: In the age of immunotherapy, cancer biologists are relying on a new generation of tools to learn how the interplay between…
h J R
Video: Dr. Mark Vincent Discusses Outcomes in Pancreatic Adenocarcinoma Patients with Genetic Alterations in DNA Da… https://t.co/35E7MSeX3V
h J R
RT @medoncdoc: CO26. first evidence of survival benefit in MSS patients using immunotherapy. 6.6 mo vs 4.1 mo.#GI19 @CDNCancerTrials great…
h J R
RT @tehfem: Adjuvant HIPEC in CRC at high risk for peritoneal mets No benefit #GI19 https://t.co/tYIw9B3eme
h J R
RT @GillSharlene: How long to optimally wait for resection after neoadjuvant therapy for early stage rectal cancer? Looks like the answer…
h J R

Other

Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma patients treated with liposomal irinotecan plus 5-fluorouracil and leucovorin (5-FU/LV) vs. 5-FU/LV alone

Hubner R, et al. ESMO 2017:741P Background Neutrophils have been shown to inhibit the activity of T cells, which is associated with a poor prognosis, while tumour-infiltrating lymphocytes are associated with better outcomes in a variety of cancers.1 High peripheral...

Twitter feed

RT @NatureNews: In the age of immunotherapy, cancer biologists are relying on a new generation of tools to learn how the interplay between…
h J R
Video: Dr. Mark Vincent Discusses Outcomes in Pancreatic Adenocarcinoma Patients with Genetic Alterations in DNA Da… https://t.co/35E7MSeX3V
h J R
RT @medoncdoc: CO26. first evidence of survival benefit in MSS patients using immunotherapy. 6.6 mo vs 4.1 mo.#GI19 @CDNCancerTrials great…
h J R
RT @tehfem: Adjuvant HIPEC in CRC at high risk for peritoneal mets No benefit #GI19 https://t.co/tYIw9B3eme
h J R
RT @GillSharlene: How long to optimally wait for resection after neoadjuvant therapy for early stage rectal cancer? Looks like the answer…
h J R